These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8548071)

  • 41. Antigenic variation among equine H 3 N 8 influenza virus hemagglutinins.
    Ozaki H; Shimizu-Nei A; Sugita S; Sugiura T; Imagawa H; Kida H
    Jpn J Vet Res; 2001 Feb; 48(4):177-86. PubMed ID: 11276582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development and application of monoclonal antibodies against avian influenza virus nucleoprotein.
    Yang M; Berhane Y; Salo T; Li M; Hole K; Clavijo A
    J Virol Methods; 2008 Feb; 147(2):265-74. PubMed ID: 18006085
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selection of receptor-binding variants of human influenza A and B viruses in baby hamster kidney cells.
    Govorkova EA; Matrosovich MN; Tuzikov AB; Bovin NV; Gerdil C; Fanget B; Webster RG
    Virology; 1999 Sep; 262(1):31-8. PubMed ID: 10489338
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells.
    Zhirnov OP; Vorobjeva IV; Saphonova OA; Poyarkov SV; Ovcharenko AV; Anhlan D; Malyshev NA
    J Clin Virol; 2009 Aug; 45(4):322-33. PubMed ID: 19546028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetically destined potentials for N-linked glycosylation of influenza virus hemagglutinin.
    Igarashi M; Ito K; Kida H; Takada A
    Virology; 2008 Jul; 376(2):323-9. PubMed ID: 18456302
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Variability of the influenza A/Hong Kong virus under laboratory conditions as affected by antibodies].
    Kudriavtseva VK; Nevedomskaia GN; Grinbaum EB; Ivanova NA; Luzianina TIa
    Tr Inst Im Pastera; 1982; 58():47-54. PubMed ID: 7187553
    [No Abstract]   [Full Text] [Related]  

  • 47. Genetic relationships, serological cross-reaction and cross-protection between H1N2 and other influenza A virus subtypes endemic in European pigs.
    Reeth KV; Brown I; Essen S; Pensaert M
    Virus Res; 2004 Jul; 103(1-2):115-24. PubMed ID: 15163499
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A modification to the chloroform-methanol method of isolating the matrix protein of the influenza virus].
    Gordienlko AI; Krivoshein IuS; Gordienko AI
    Mikrobiol Z; 1998; 60(3):91-5. PubMed ID: 9785805
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of a novel influenza hemagglutinin, H15: criteria for determination of influenza A subtypes.
    Röhm C; Zhou N; Süss J; Mackenzie J; Webster RG
    Virology; 1996 Mar; 217(2):508-16. PubMed ID: 8610442
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin.
    Abe Y; Takashita E; Sugawara K; Matsuzaki Y; Muraki Y; Hongo S
    J Virol; 2004 Sep; 78(18):9605-11. PubMed ID: 15331693
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influenza A virus-specific H-2d restricted cross-reactive cytotoxic T lymphocyte epitope(s) detected in the hemagglutinin HA2 subunit of A/Udorn/72.
    Saikh KU; Martin JD; Nishikawa AH; Dillon SB
    Virology; 1995 Dec; 214(2):445-52. PubMed ID: 8553546
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.
    Govorkova EA; Kodihalli S; Alymova IV; Fanget B; Webster RG
    Dev Biol Stand; 1999; 98():39-51; discussion 73-4. PubMed ID: 10494958
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Identification of influenza virus type A by solid-phase radioimmunological analysis].
    Ignat'eva TV; Trushinskaia GN; Isaeva EI
    Vopr Virusol; 1985; 30(1):53-7. PubMed ID: 3993004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A humanized anti-M2 scFv shows protective in vitro activity against influenza.
    Gabbard J; Velappan N; Di Niro R; Schmidt J; Jones CA; Tompkins SM; Bradbury AR
    Protein Eng Des Sel; 2009 Mar; 22(3):189-98. PubMed ID: 19054791
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antigenic drift and variability of influenza viruses.
    Schweiger B; Zadow I; Heckler R
    Med Microbiol Immunol; 2002 Dec; 191(3-4):133-8. PubMed ID: 12458347
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Use of monoclonal antibodies in virology].
    Lashkevich VA
    Vopr Virusol; 1983; 28(6):648-54. PubMed ID: 6322450
    [No Abstract]   [Full Text] [Related]  

  • 57. [Identification of the hemagglutinating antigens of the influenza virus by immunoenzyme analysis].
    Isaeva EI; Rovnova ZI; Selivanov IaM
    Vopr Virusol; 1988; 33(5):538-43. PubMed ID: 3064428
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hybridomas producing monoclonal antibodies to influenza viruses].
    Kushch AA; Tsoĭ LA; Isaeva EI; Rovnova ZI; Ivanova LA
    Vopr Virusol; 1985; 30(1):22-4. PubMed ID: 3887755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HA2-specific monoclonal antibodies as tools for differential recognition of influenza A virus antigenic subtypes.
    Varecková E; Mucha V; Kostolanský F; Gubareva LV; Klimov A
    Virus Res; 2008 Mar; 132(1-2):181-6. PubMed ID: 18037184
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alteration in the antigenic structure of M1 protein of influenza A virus mutant resistant to a new antiviral compound mopyridone.
    Galabov AS; Khristova ML; Uzunov S; Wassilewa L; Bucher DJ; Kharitonenkov IG
    Acta Virol; 1994 Feb; 38(1):5-10. PubMed ID: 7520664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.